FTC sues important pharmacy advantage managers around insulin prices The company brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of life-preserving insulin medications. Elevance lowers steerage on ‘unprecedented’ Medicaid challenges Executives claimed the improved expense... https://dave-s-hot-chicken-nutrit28495.suomiblog.com/not-known-facts-about-healthcare-news-46314072